Table 7.

Previous potentially hip fracture associated medication

			Women n = 91	Men n = 127	Total n = 218
Previous use of potentially hip fracture associated medication			34 (37%)	36 (29%)	70 (32%)
ATC code	Example of use/diagnosis	Example of medication name
A02BC Proton pump inhibitors	Peptic ulcer, gastro-oesophageal reflux disease	Omeprazole, pantoprazole, lansoprazole	12 (13%)	7 (6%)	19 (9%)
N06AB Selective serotonin reuptake inhibitors	Antidepressants	Citalopram, sertraline, fluoxetine	10 (11%)	8 (6%)	18 (8%)
N02A Opioids	Pain	Morphine, methadone, fentanyl	8 (9%)	7 (6%)	15 (7%)
H02AB Glucocorticoids	Systemic corticosteroids	Prednisolone, betamethasone, hydrocortisone	6 (7%)	6 (5%)	12 (6%)
B01A Antithrombotic agents	Antithrombotic therapy	Heparin, dalteparin, warfarin	4 (4%)	8 (6%)	12 (6%)
N03AF Carboxamide derivates	Antiepileptics	Carbamazepine, oxcarbazepine, rufinamide	5 (5%)	5 (4%)	10 (5%)
C03CA Loop-diuretics	Hypertension, heart failure	Furosemide	5 (5%)	4 (3%)	9 (4%)
M01A NSAID	RA, osteoarthrosis, pain	Diclofenac, ibuprofen	4 (4%)	5 (4%)	9 (4%)
H03AA Thyroid hormones	Hypothyreosis	Levothyroxine, liothyronine	7 (8%)	1 (1%)	8 (4%)
M05B Bisphosphonates	Osteoporosis	Aledronic acid, zoledronic acid	3 (3%)	4 (3%)	7 (3%)
G03 Sex hormones	Hormonal therapy	Androgens, estrogens	3 (3%)	2 (2%)	5 (2%)
L01, L04 Antineoplastic and immunomodulating agents	Cancer, rheumatoid arthritis	Cyklophosphamide, busulfan, methotrexate	2 (2%)	2 (2%)	4 (2%)
L02BG Aromatase inhibitors	Cancer (breast, endometrial, prostatic)	Anastrozole, letrozole, exemestane	1 (1%)	0	1 (0.5%)
G03AC06 Progestogens	Contraceptive	Medroxyprogesterone	1 (1%)	0	1 (0.5%)